Pediatrics
Showing 541-560 of 856 Results
-
Keith Morse
Clinical Associate Professor, Pediatrics
BioKeith Morse, MD, MBA, serves as the Chief Medical Informatics Officer (CMIO) for Stanford Medicine Children's Health. He practices clinically as a pediatric hospitalist and is the Program Director for Stanford's Clinical Informatics fellowship.
-
Richard B. Moss
Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsImmunopathogenesis of chronic airways diseases of childhood, including cystic fibrosis, asthma, allergic aspergillosis and bronchopulmonary dysplasia. Translational research: early clinical trials in airways disease of childhood, most notably CF, including gene, cytokine and drug therapy. Recent projects focus on development of biomarkers and treatments for allergic fungal lung disease, e.g. inhaled antifungals.
-
Kara Motonaga
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsArrhythmias in Pediatric and Adult Congenital Heart Disease
-
Daniel Murphy
Professor of Pediatrics (Cardiology), Emeritus
Current Research and Scholarly InterestsDr. Murphy's major interests are in noninvasive cardiology and clinical pediatric and adult congenital cardiac disease. These clinical interests range from imaging of complex cardiac disease in the fetus and newborn to care of the adult with congenital heart disease. He also coordinates the Marfan clinic at LPCH. He is the director of the Adult Congenital Cardiac Clinic at Stanford University Medical Center.
-
Urs Naber
Clinical Associate Professor, Pediatrics - Critical Care
BioDr. Naber is the medical director for the pediatric intensive care unit at California Pacific Medical Center. His research focuses on value based development of medical technology for every part of the patient care chain.
-
Shweta S. Namjoshi MD MPH
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly Interests1. The mission of the International Intestinal Failure Registry (IIFR) is to provide the international intestinal rehabilitation and transplant community with accurate data on the outcomes and course of intestinal failure to support research, quality improvement, and policy development. https://tts.org/irta-registries/irta-ifr
2. NCT05241444 is the first-in-human, Phase 1 clinical trial will test the feasibility of the manufacturing and the safety of the administration of CD4^LVFOXP3 in up to 36 evaluable human participants with IPEX and evaluate the impact of the CD4^LVFOXP3 infusion on the disease.
3. Stanford's local Intestinal Failure Registry (SIFR) ensures ongoing assessment and improvement of intestinal failure outcomes and care provided at Stanford in collaboratiton with the Division of Pediatric Surgery. This registry focuses on clinical outcomes and social developmental outcomes for patients with short bowel syndrome, pediatric CODEs, and pseudoobstruction. -
Amrita Narang
Clinical Associate Professor, Pediatrics - Gastroenterology
BioMy clinical and research interests are in neonatal cholestatic liver diseases, including biliary atresia and fatty liver disease. I'm also highly experienced in liver transplant care, with a particular focus on teen and transition of care.
In addition to my clinical and research work, I'm deeply committed to medical education and patient education. I believe that knowledge is power, and I strive to empower my patients and their families with the resources and information they need to make informed decisions about their care.
As a physician, I'm dedicated to providing the highest level of care to my patients and their families. I believe that every child deserves the best possible chance at a healthy and fulfilling life, and I'm honored to play a role in helping them achieve that goal. -
Diana Naranjo
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioAs a licensed clinical psychologist working in diabetes and Cystic Fibrosis clinics for the past 10 years, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes and CF. Through clinical research, she aims to understand barriers and facilitators to diabetes self-management, how families and individuals with diabetes respond to health technology, and how to best provide services that engage youth and their families. She is a member of the Stanford Diabetes Research Center.
